This is a preview of subscription content, log in via an institution to check access.
References
Tollyma P, Guy P et al. A Revolution in R&D. Boston Consulting Group: Boston, 2001.
Weber W . Pharmacogenetics. Oxford Press: Oxford, 1997.
See for example Genetic Screening (Nuffield Council on Bioethics, 1993) and Inside Information (Human Genetics Commission, 2002).
Author information
Authors and Affiliations
Corresponding author
Additional information
DUALITY OF INTEREST
None declared.
Rights and permissions
About this article
Cite this article
Lipton, P. Pharmacogenetics: the ethical issues. Pharmacogenomics J 3, 14–16 (2003). https://doi.org/10.1038/sj.tpj.6500159
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500159
- Springer Nature Limited
This article is cited by
-
Genetic Testing for Opioid Pain Management: A Primer
Pain and Therapy (2017)
-
Pharmacogenomics Education: International Society of Pharmacogenomics Recommendations for Medical, Pharmaceutical, and Health Schools Deans of Education
The Pharmacogenomics Journal (2005)
-
Protecting communities in pharmacogenetic and pharmacogenomic research
The Pharmacogenomics Journal (2004)
-
Economic and regulatory considerations in pharmacogenomics for drug licensing and healthcare
Nature Biotechnology (2003)